The 7.59x EV/EBITDA multiple appears modest against peers such as Silgan at 8.06x and News Corporation at 10.27x, but it is set against EBITDA that has been compressed by fixed-cost deleverage, so the apparent cheapness may reflect a lower earnings base rather than undervaluation. The 1.20x price-to-book ratio is also less informative than usual because shareholder equity has turned negative, which means book value no longer offers a floor. Investors should monitor whether forward EV/EBITDA of 8.02x reflects expected EBITDA recovery or simply a higher multiple on a shrinking base.

The gap between a gross margin of 3.9% and an operating margin of negative 51.3% in the latest quarter suggests that selling, general, and administrative costs or impairment-related charges are consuming nearly all remaining gross profit, which points to a cost base that has not adjusted to lower volumes. Net margin of negative 60.1% is far more severe than the operating result, implying below-the-line charges that warrant further investigation before underlying earning power can be judged. On a normalized basis, the business appears to be operating at or below breakeven, and the recovery in gross margin alone appears insufficient to restore profitability.

ROIC in the range of negative 18.2% to 1.5% across the ten quarters suggests that the invested capital base, which includes roughly $736M to $822M of debt, is generating little or no economic return. Because ROE becomes unstable once equity approaches zero, the negative ROE readings should be interpreted as a signal of capital erosion rather than a performance ratio that can be compared directly against peers. Peer ROIC values of around 6% to 9% at Sonoco and Silgan indicate that RYAM's returns appear to lag materially, and the gap looks structural rather than purely cyclical given the sustained trend.

The rise in leverage appears driven by shrinking equity rather than new borrowing, since total debt has remained broadly stable, which means the risk profile has deteriorated even without incremental debt issuance. Negative interest coverage in several recent quarters implies operating earnings do not cover interest expense, a condition that typically narrows refinancing options. Debt/EBITDA reaching 8.33x in 2026Q2 and the absence of positive coverage readings warrant close monitoring of covenant headroom and maturity schedules, though specific covenant terms are not included in the supplied data.

A quick ratio below 1.0 combined with a current ratio that has compressed by roughly a quarter suggests the company would depend on converting inventory, which carries inventory days of 47 to 70, to cover short-term obligations under stress. The declining cash balance alongside persistent operating losses implies the liquidity buffer is being drawn down rather than rebuilt. Under a severe demand or pricing shock, the combination of fixed operating costs and limited cash could leave limited flexibility, though this inference depends on data not fully disclosed in the supplied figures.